The Discounted Cash Flow (DCF) valuation of Ascletis Pharma Inc (1672.HK) is (2.70) HKD. With the latest stock price at 7.00 HKD, the upside of Ascletis Pharma Inc based on DCF is -138.6%.
Based on the latest price of 7.00 HKD and our DCF valuation, Ascletis Pharma Inc (1672.HK) is a sell. selling 1672.HK stocks now will result in a potential gain of 138.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 8.4% - 11.7% | 10.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.23) - (1.70) | (2.70) |
| Upside | -174.7% - -124.3% | -138.6% |